ClinVar Miner

Submissions for variant NM_030777.4(SLC2A10):c.238G>A (p.Gly80Arg)

gnomAD frequency: 0.00010  dbSNP: rs369865870
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000521208 SCV000619191 uncertain significance not provided 2017-07-14 criteria provided, single submitter clinical testing A variant of uncertain significance has been identified in the SLC2A10 gene. The G80R variant has not been published as pathogenic or been reported as benign to our knowledge. The G80R variant is observed in 4/10342 (0.04%) alleles from individuals of African background in the Exome Aggregation Consortium (ExAC) dataset, and no individuals were reported to be homozygous (Lek et al., 2016). The G80R variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. However, this substitution occurs at a position that is not conserved and in silico analysis predicts this variant likely does not alter the protein structure/function.Therefore, based on the currently available information, it is unclear whether this variant is pathogenic or rare benign.
Ambry Genetics RCV002431483 SCV002731940 uncertain significance Familial thoracic aortic aneurysm and aortic dissection 2021-01-12 criteria provided, single submitter clinical testing The p.G80R variant (also known as c.238G>A), located in coding exon 2 of the SLC2A10 gene, results from a G to A substitution at nucleotide position 238. The glycine at codon 80 is replaced by arginine, an amino acid with dissimilar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
PreventionGenetics, part of Exact Sciences RCV003403236 SCV004120342 uncertain significance SLC2A10-related condition 2023-07-11 criteria provided, single submitter clinical testing The SLC2A10 c.238G>A variant is predicted to result in the amino acid substitution p.Gly80Arg. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.032% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/20-45353913-G-A). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.